This approach suits people who dislike daily injections or who have transitioned into a maintenance phase after an initial loading cycle
Originally created as a lipolytic compound for treating obesity, AOD-9604 has demonstrated potential in animal studies for treating heart disease, osteoarthritis, and metabolic syndrome by promoting cartilage repair and fat breakdown while inhibiting fat creation
In some cases, researchers prefer using a higher initial dose and lower maintenance doses
Professional medical evaluation
Nucleic Acids Res 53:D543d553 Russell DG, VanderVen BC, Lee W, Abramovitch RB, Kim MJ, Homolka S, Niemann S, Rohde KH (2010) Mycobacterium tuberculosis wears what it eats
Because these injections are intramuscular, the nutrients bypass the digestive system